News Related to Zevorcabtagene Autoleucel

Related coverage linked through entity extraction aliases.

Multiple Myeloma Pipeline Expands With 80+ Therapies as Treatment Paradigms Evolve

Mar 20, 2026

The multiple myeloma treatment landscape is rapidly expanding with over 75 companies developing 80+ pipeline therapies, while clinicians navigate evolving questions about transplant timing, quadruplet regimens, and minimal residual disease testing in newly diagnosed patients.

CAR T-Cell Therapy Market Expands with AI Integration and Pipeline Growth

Feb 27, 2026

CAR T-cell therapy market advances with AI-driven manufacturing improvements and over 250 companies developing 500+ drug candidates, including breakthrough solid tumor treatments and GPC3-targeted therapies for hepatocellular carcinoma.